淋巴瘤的基因信息治疗:结块分裂的令人不安的好处
Cynthia K Hahn1, Adam C Palmer2, David M Weinstock3
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Cancer cell
|September 29, 2023
概括
个性化药物显著改善了扩散性大B细胞淋巴瘤 (DLBCL) 患者的治疗结果. 一个第二阶段试验显示,R-CHOP加上向药物的效果优于标准R-CHOP,为更大规模的研究铺平了道路.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 临床试验 临床试验
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种侵略性的非霍奇金淋巴瘤.
- 目前的标准治疗,R-CHOP,对一些患者的疗效有局限性.
- 了解淋巴瘤遗传学的进步为向治疗提供了机会.
研究的目的:
- 在DLBCL中评估个性化医疗方法的有效性.
- 为了比较标准的R-CHOP与R-CHOP加上基因匹配的药物.
- 为第三阶段试验奠定基础,调查向DLBCL治疗方法.
主要方法:
- 进行了一项随机的2期临床试验.
- 患者接受了标准R-CHOP或R-CHOP与五种药物之一相结合.
- 药剂的选择是基于个体淋巴瘤的遗传特征.
主要成果:
- 与标准的R-CHOP相比,个性化治疗策略显示出明显的改善结果.
- 这种有针对性的方法在第二阶段试验中显示出更高的疗效.
- 对于这五种药物,没有提到具体的结果.
结论:
- 基因引导疗法代表了DLBCL治疗的有希望的范式转变.
- 个性化医疗策略需要在更大的临床试验中进行进一步的研究.
- 这些发现支持开发针对DLBCL向治疗的第三阶段试验.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.4K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
812
相关概念视频
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
